Soken Chemical & Engineering Co. Ltd
Soken Chemical & Engineering Co., Ltd. manufactures and sells acrylic pressure-sensitive adhesives, functional polymers, organic fine particles, and adhesive tapes in Japan, China, and internationally. Its pressure-sensitive adhesives are used for a range of applications in industrial fields, including IT devices, automobiles, building materials, and electronics and optical devices, as well as in… Read more
Soken Chemical & Engineering Co. Ltd (SOQ) - Net Assets
Latest net assets as of September 2025: €37.92 Billion EUR
Based on the latest financial reports, Soken Chemical & Engineering Co. Ltd (SOQ) has net assets worth €37.92 Billion EUR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€53.02 Billion) and total liabilities (€15.10 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €37.92 Billion |
| % of Total Assets | 71.51% |
| Annual Growth Rate | 6.77% |
| 5-Year Change | 48.5% |
| 10-Year Change | N/A |
| Growth Volatility | 5.7 |
Soken Chemical & Engineering Co. Ltd - Net Assets Trend (2016–2025)
This chart illustrates how Soken Chemical & Engineering Co. Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Soken Chemical & Engineering Co. Ltd (2016–2025)
The table below shows the annual net assets of Soken Chemical & Engineering Co. Ltd from 2016 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | €38.00 Billion | +16.09% |
| 2024-03-31 | €32.74 Billion | +9.20% |
| 2023-03-31 | €29.98 Billion | +5.75% |
| 2022-03-31 | €28.35 Billion | +10.77% |
| 2021-03-31 | €25.59 Billion | +10.09% |
| 2020-03-31 | €23.24 Billion | +3.08% |
| 2019-03-31 | €22.55 Billion | +0.69% |
| 2018-03-31 | €22.39 Billion | +10.29% |
| 2017-03-31 | €20.31 Billion | -3.67% |
| 2016-03-31 | €21.08 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Soken Chemical & Engineering Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 130.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €26.03 Billion | 68.50% |
| Other Components | €11.97 Billion | 31.50% |
| Total Equity | €38.00 Billion | 100.00% |
Soken Chemical & Engineering Co. Ltd Competitors by Market Cap
The table below lists competitors of Soken Chemical & Engineering Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Melhus Sparebank
OL:MELG
|
$48.50 Million |
|
MedPeerInc
PINK:MDPEF
|
$48.50 Million |
|
Jyong Biotech Ltd. Ordinary Shares
NASDAQ:MENS
|
$48.51 Million |
|
MKH Bhd
KLSE:6114
|
$48.51 Million |
|
Rorze Systems Corporation
KQ:071280
|
$48.46 Million |
|
Blau Farmacêutica S.A
SA:BLAU3
|
$48.45 Million |
|
Zeotech Ltd
AU:ZEO
|
$48.41 Million |
|
Burcelik Bursa Celik Dokum Sanayi AS
IS:BURCE
|
$48.39 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Soken Chemical & Engineering Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 32,735,381,000 to 38,003,154,000, a change of 5,267,773,000 (16.1%).
- Net income of 4,378,529,000 contributed positively to equity growth.
- Dividend payments of 785,078,000 reduced retained earnings.
- Share repurchases of 240,000 reduced equity.
- Other factors increased equity by 1,674,562,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €4.38 Billion | +11.52% |
| Dividends Paid | €785.08 Million | -2.07% |
| Share Repurchases | €240.00K | -0.0% |
| Other Changes | €1.67 Billion | +4.41% |
| Total Change | €- | 16.09% |
Book Value vs Market Value Analysis
This analysis compares Soken Chemical & Engineering Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-03-31 | €2450.56 | €6.33 | x |
| 2018-03-31 | €2702.69 | €6.33 | x |
| 2019-03-31 | €2721.45 | €6.33 | x |
| 2020-03-31 | €2829.19 | €6.33 | x |
| 2021-03-31 | €3114.78 | €6.33 | x |
| 2022-03-31 | €1717.84 | €6.33 | x |
| 2023-03-31 | €1813.17 | €6.33 | x |
| 2024-03-31 | €1976.40 | €6.33 | x |
| 2025-03-31 | €2292.11 | €6.33 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Soken Chemical & Engineering Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.52%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 9.19%
- • Asset Turnover: 0.88x
- • Equity Multiplier: 1.42x
- Recent ROE (11.52%) is above the historical average (7.38%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 2.66% | 2.03% | 0.79x | 1.66x | €-1.46 Billion |
| 2017 | 6.61% | 5.14% | 0.80x | 1.61x | €-687.65 Million |
| 2018 | 8.77% | 6.54% | 0.81x | 1.65x | €-274.90 Million |
| 2019 | 6.49% | 4.67% | 0.85x | 1.62x | €-792.10 Million |
| 2020 | 7.04% | 5.70% | 0.81x | 1.52x | €-688.59 Million |
| 2021 | 10.65% | 8.65% | 0.78x | 1.58x | €165.70 Million |
| 2022 | 7.20% | 5.28% | 0.85x | 1.61x | €-794.12 Million |
| 2023 | 4.79% | 3.77% | 0.81x | 1.58x | €-1.56 Billion |
| 2024 | 8.03% | 6.36% | 0.82x | 1.55x | €-644.24 Million |
| 2025 | 11.52% | 9.19% | 0.88x | 1.42x | €578.21 Million |
Industry Comparison
This section compares Soken Chemical & Engineering Co. Ltd's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $18,803,803,535
- Average return on equity (ROE) among peers: -24.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Soken Chemical & Engineering Co. Ltd (SOQ) | €37.92 Billion | 2.66% | 0.40x | $48.50 Million |
| Kureha Corporation (0K1) | $162.17 Billion | 8.59% | 0.53x | $845.56 Million |
| Polwax S.A (1LW) | $54.23 Million | -71.97% | 1.06x | $3.33 Million |
| H&R GmbH & Co. KGaA (2HRA) | $287.13 Million | 9.37% | 1.19x | $34.48 Million |
| Renaissance Oil Corp (2R7) | $2.68 Billion | 6.64% | 1.08x | $1.31 Billion |
| Global New Material International Holdings Limited (69Y) | $4.35 Billion | 5.56% | 0.62x | $625.83 Million |
| Altech Chemicals Ltd (A3Y) | $33.88 Million | -176.29% | 0.32x | $18.88 Million |
| Beijing Media Corporation Limited (BME) | $1.20 Billion | -7.10% | 0.16x | $1.77 Million |
| BRAIN Biotech AG (BNN) | $17.59 Million | -23.28% | 0.43x | $40.42 Million |
| Brenntag SE (BNR) | $2.69 Billion | 13.57% | 1.59x | $5.87 Billion |
| Huabao International Holdings Limited (CEY) | $14.56 Billion | -7.24% | 0.14x | $1.44 Billion |